PetVivo Holdings, Inc. (PETV)

Market Cap	18.23M -56.6%
Revenue (ttm)	1.18M -9.5%
Net Income	-9.87M
EPS	-0.30
Shares Out	37.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,612
Open	0.5257
Previous Close	0.5500
Day's Range	0.4686 - 0.5257
52-Week Range	0.4686 - 1.4400
Beta	1.44
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About PetVivo Holdings

PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company’s lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. The company is based in Edina, Minnesota.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: John Lai
• Employees: 22
• Stock Exchange: OTCMKTS
• Ticker Symbol: PETV

Financial Performance

In fiscal year 2026, PetVivo Holdings's revenue was $1.14 million, an increase of 0.80% compared to the previous year's $1.13 million. Losses were -$10.47 million, 24.7% more than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 12, 2026

Data Sources Report a data error